Methods of testing for bronchial asthma or chronic obstructive pulmonary disease
    3.
    发明申请
    Methods of testing for bronchial asthma or chronic obstructive pulmonary disease 审中-公开
    支气管哮喘或慢性阻塞性肺疾病的检测方法

    公开(公告)号:US20050208496A1

    公开(公告)日:2005-09-22

    申请号:US10631467

    申请日:2003-07-31

    摘要: An objective of the present invention is to provide a method of testing for bronchial asthma or chronic obstructive pulmonary disease, a method of screening for candidate compounds for treating bronchial asthma or chronic obstructive pulmonary disease, and a pharmaceutical agent for treating bronchial asthma or chronic obstructive pulmonary disease. The present invention identified genes whose expression levels varied between respiratory epithelial cells that had been stimulated by IL-13 to induce the goblet cell differentiation, and unstimulated respiratory epithelial cells. The respiratory epithelial cells were cultured according to the air interface method. The genes were revealed to be useful as markers for testing for bronchial asthma or chronic obstructive pulmonary disease and screening for therapeutic agents for such diseases. Specifically, the present invention provides methods of testing for bronchial asthma or chronic obstructive pulmonary disease and methods of screening for compounds to treat the diseases based on the comparison of the expression levels of marker genes identified as described above.

    摘要翻译: 本发明的目的是提供支气管哮喘或慢性阻塞性肺疾病的检测方法,用于治疗支气管哮喘或慢性阻塞性肺疾病的候选化合物的筛选方法,以及用于治疗支气管哮喘或慢性阻塞性肺病的药剂 肺病。 本发明鉴定了由IL-13刺激的呼吸上皮细胞诱导杯状细胞分化的表达水平变化的基因和未刺激的呼吸上皮细胞。 根据空气界面方法培养呼吸道上皮细胞。 这些基因被揭示为可用作测试支气管哮喘或慢性阻塞性肺疾病和筛选这些疾病的治疗剂的标记物。 具体地,本发明提供了用于支气管哮喘或慢性阻塞性肺疾病的检测方法以及基于如上所述鉴定的标记基因的表达水平的比较来筛选化合物治疗疾病的方法。